Rockefeller Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-104,543
| Closed | -$1.45M | – | 1729 |
|
|
2024
Q1 | $1.45M | Buy |
+104,543
| New | +$1.45M | ﹤0.01% | 1132 |
|
|
2023
Q1 | – | Sell |
-2,515
| Closed | -$37K | – | 3683 |
|
|
2022
Q4 | $37K | Sell |
2,515
-610
| -20% | -$8.97K | ﹤0.01% | 2537 |
|
|
2022
Q3 | $38K | Sell |
3,125
-38
| -1% | -$462 | ﹤0.01% | 2492 |
|
|
2022
Q2 | $43K | Sell |
3,163
-5,319
| -63% | -$72.3K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $119K | Buy |
8,482
+5,915
| +230% | +$83K | ﹤0.01% | 1911 |
|
|
2021
Q4 | $33K | Sell |
2,567
-813
| -24% | -$10.5K | ﹤0.01% | 2403 |
|
|
2021
Q3 | $54K | Buy |
3,380
+671
| +25% | +$10.7K | ﹤0.01% | 2107 |
|
|
2021
Q2 | $45K | Buy |
2,709
+140
| +5% | +$2.33K | ﹤0.01% | 2131 |
|
|
2021
Q1 | $46K | Buy |
2,569
+598
| +30% | +$10.7K | ﹤0.01% | 1923 |
|
|
2020
Q4 | $35K | Sell |
1,971
-712
| -27% | -$12.6K | ﹤0.01% | 1799 |
|
|
2020
Q3 | $47K | Buy |
2,683
+624
| +30% | +$10.9K | ﹤0.01% | 1525 |
|
|
2020
Q2 | $37K | Sell |
2,059
-555
| -21% | -$9.97K | ﹤0.01% | 1492 |
|
|
2020
Q1 | $40K | Sell |
2,614
-15,454
| -86% | -$236K | ﹤0.01% | 1303 |
|
|
2019
Q4 | $357K | Sell |
18,068
-982
| -5% | -$19.4K | ﹤0.01% | 637 |
|
|
2019
Q3 | $327K | Buy |
19,050
+539
| +3% | +$9.25K | ﹤0.01% | 539 |
|
|
2019
Q2 | $328K | Sell |
18,511
-41,176
| -69% | -$730K | ﹤0.01% | 505 |
|
|
2019
Q1 | $1.22M | Buy |
+59,687
| New | +$1.22M | 0.02% | 343 |
|